Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats

Brain Research

Volumn 806, Issue 1, 1998, Pages 60-68

  Clarkson, Edward D ^a   Zawada, W Michael ^a   Adams, Frank S ^a   Bell, K Pat ^a   Freed, Curt R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Apoptosis; BFGF; GDNF; Growth factors; IGF I; Matrigel; Methamphetamine

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MATRIGEL; METHAMPHETAMINE; OXIDOPAMINE; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CELL SURVIVAL; CELL SUSPENSION; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYONAL TISSUE; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TRANSPLANTATION;

ANIMALS; BEHAVIOR, ANIMAL; CELL SIZE; CELL SURVIVAL; CELL TRANSPLANTATION; DOPAMINE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; MALE; MESENCEPHALON; METHAMPHETAMINE; NEURONS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR;

EID: 0032556063     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00717-3     Document Type: Article

References (41)

1. Abercrombie M. Estimation of nuclear population from microtome sections. The Anatomical Record. 94:1946;239-247.
2. Björklund A., Stenevi U. Intracerebral neural implants: neuronal replacement and reconstruction of damaged circuitries. Annu. Rev. Neurosci. 7:1984;279-308.
3. Brundin P., Isacson O., Björklund A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:1985;251-259.
4. Brundin P., Isacson O., Gage F.H., Björklund A. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: effects of mixing with target or non-target cells. Brain Res. 389:1986;77-84.
5. Brundin P., Barbin G., Strecker R.E., Isacson O., Prochiantz A., Björklund A. Survival and function of dissociated rat dopamine neurones grafted at different development stages or after being cultured in vitro. Dev. Brain Res. 39:1988;233-243.
6. Clarkson E.D., Zawada W.M., Freed C.R. GDNF reduces apoptosis in dopaminergic neurons in vitro. NeuroReport. 7:1995;145-149.
7. Clarkson E.D., Zawada W.M., Freed C.R. GDNF improves survival and reduces apoptotic cell death in human embryonic dopaminergic neurons in vitro. Cell Tissue Res. 289:1997;207-210.
8. Clarkson E.D., La Rosa F.G., Edwards-Prasad J., Weiland D.A., Witta S.E., Freed C.R., Prasad K.N. Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells. Proc. Natl. Acad. Sci. USA. 95:1998;1265-1270.
9. Coggeshall R.E., Lekan H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J. Comp. Neurol. 364:1996;6-15.
10. Costantini L.C., Vozza B.M., Snyder-Keller A.M. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: an anatomical and behavioral analysis. Exp. Neurol. 127:1994;219-231.
11. Dunnett S.B., Björklund A., Stenevi U., Iversen S.D. Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akeinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res. 229:1981;209-217.
12. Ehringer H., Hornykiewicz O. Verteilung von noradrenalin and dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin. Wochenschr. 38:1960;1236-1239.
13. Fawcett J.W., Barker R.A., Dunnett S.B. Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp. Brain Res. 106:1995;275-282.
14. Freed C.R., Breeze R.E., Rosenberg N.L., Schneck S.A., Wells T.H., Barrett J.N., Grafton S.T., Huang S.C., Eidelberg D., Rottenberg D.A. Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. Arch. Neurol. 47:1990;505-512.
15. C.R. Freed, R.E. Breeze, N.L. Rosenberg, S.A. Schneck, G. Schroter, K. Lafferty, D.W. Talmage, J.N. Barrett, T. Wells, J.C. Mazziotta, D. Huang, D. Eidelberg, D.A. Rottenberg, 1991. Fetal neural implants for Parkinson's disease: results at 15 months. In: Restorative Neurology, Intracerebral Transplantation in Movement Disorders. Elsevier, Amsterdam, 4, pp. 69-77.
16. Freed C.R., Breeze R.E., Rosenberg N.L., Schneck S.A., Kriek E., Qi J.X., Lone T., Zhang Y.B., Synder J.A., H Wells T.et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplant for Parkinson's disease. New Engl. J. Med. 327:1992;1549-1555.
17. Freeman T.B., Olanow C.W., Hauser R.A., Nauert G.M., Smith D.A., Borlongan C.V., Sanberg P.R., Holt D.A., Kordower J.H., Vingerhoets F.J.et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38:1995;379-388.
18. Haber S., Finklestein S.D., Benowitz L.I., Sladek J.R. Jr., Collier T.J. Matrigel enhances survival and integration of grafted dopamine neurons into the striatum. Prog. Brain Res. 78:1988;427-433.
19. Heim R.C., Willingham G., Freed W.J. A comparison of solid intraventricular and dissociated intraparenchymal fetal substania nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior. Exp. Neurol. 122:1993;5-15.
20. Kearns C.M., Gash D.M. GDNF protects nigral dopamine neurons against 6- hydroxydopamine in vivo. Brain Res. 672:1995;104-111.
21. Knusel B., Michel P.P., Schwaber J.S., Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and insulin-like growth factors I and II. J. Neurosci. 10:1990;558-570.
22. Kopyov O.V., Jacques D., Lieberman A., Duma C.M., Rogers R.L. Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell Transplant. 5:1996;327-337.
23. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P.et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. New Engl. J. Med. 322:1995;1118-1124.
24. Laird N.M., Ware J.H. Random effects for longitudinal data. Biometrics. 38:1982;963-974.
25. Leigh K., Ellisevich K., Rogers K.A. Vascularization and microvascular permeability in solid versus cell-suspension embryonic neural grafts. J. Neurosurg. 81:1994;272-283.
26. Lin L.-F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
27. R.C. Littell, G.A. Milliken, W.W. Stroups, R.D. Wolfinger (Eds.), SAS System for Mixed Models, SAS Insitute, Cary, NC, 1996, Chap. 4.
28. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothwell J.C., Marsden C.D., Björklund A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 247:1990;574-577.
29. Mahalik T.J., Hahn W.E., Clayton G.H., Owens G.P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129:1994;27-36.
30. O'Malley E.K., Sieber B.A., Black I.B., Dreyfus C.F. Mesencephalic type I astrocytes mediate the survival of substania nigra dopaminergic neurons in culture. Brain Res. 582:1992;65-70.
31. G. Paxinos, C. Watson, 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
32. Richards J.B., Sabol K.E., Freed C.R. Unilateral dopamine depletion causes bilateral deficits in conditioned rotation in rats. Pharmacol. Biochem. Behav. 36:1990;217-223.
33. B Richards J., Sabol K.E., Kriek E.H., Freed C.R. Trained and amphetamine-induced circling behavior in lesioned, transplanted rats. J. Neural Trans. Plastic. 4:1993;157-166.
34. Sladek Jr J.R., Collier T.J., Elsworth J.D., Taylor J.R., H Roth R., Redmond Jr D.E. Can graft-derived neurotrophic activity be used to direct axonal outgrowth of grafted dopamine neurons for circuit reconstruction in primates? Exp. Neurol. 124:1993;134-139.
35. Spencer D.D., Robbins R.J., Naftolin F., Marek K.L., Vollmer T., Leranth C., Roth R.H., Price L.H., Gjedde A., Bunney B.S.et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. New Engl. J. Med. 327:1992;1541-1548.
36. Takayama H., Ray J., Raymon H.K., Baird A., Hogg J., Fisher L.J., Gage F.H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Med. 1:1995;53-58.
37. Widner H., Tetrud J., Rehncrona S., Snow B., Brundin P., Gustavii B., Björklund A., Lindvall O., Langston J.W. Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). New Engl. J. Med. 327:1992;1556-1563.
38. Yurek D.M., Collier T.J., Sladek Jr J.R. Embryonic mesencephalic and striatal co-grafts: development of grafted dopamine neurons and functional recovery. Exp. Neurol. 109:1990;191-199.
39. Zawada W.M., Kirschman D.L., Cohen J.J., Heidenreich K.A., Freed C.R. Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp. Neurol. 140:1996;60-67.
40. Zawada W.M., Zastrow D.J., Clarkson E.D., Adams F.S., Bell K.P., Freed C.R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786:1998;96-103.
41. Zawada W.M., Cibelli J.B., Choi P.K., Clarkson E.D., Golueke P.J., Witta S.E., Bell K.P., Kane J., Ponce De Leon F.A., Jerry D.J., Robl J.M., Freed C.R., Stice S.L. Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats. Nature Med. 4:1998;569-574.